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Abstract
Obstructive sleep apnea (OSA) is a frequent sleep disorder characterized by 
repetitive interruption of ventilation caused by partial or complete collapse of the 
upper airway during sleep. OSA is highly prevalent in the world and it has been 
associated with cardiovascular disease and cognitive impairment in children and 
adults. The cognitive impairment in individuals with OSA includes deficiencies in 
attention and constructional abilities, delayed long-term visual and verbal memory, 
and executive functions. Although, the pathogenesis of cognitive impairment 
in patients with OSA is complex and remains incompletely understood, several 
mechanisms, such as hypoxia, inflammation and sleep fragmentation have been 
proposed. The aim of this chapter is to describe some findings reported in the 
literature to explain the association between OSA and cognitive impairment.
Keywords: obstructive sleep apnea, cognitive impairment, hypoxia, sleep 
fragmentation
1. Introduction
Obstructive sleep apnea (OSA) is a breathing disorder of sleep produced by 
partial or complete obstruction of the upper airways. This sleep disorder is char-
acterized by breathing cessation and reduction of airflow resulting in temporary 
decrease, in cerebral oxygenation and sleep disruption [1]. The prevalence of OSA 
is approximately 10% in men and 3% in women between the ages of 30–49%, but 
rising to 17% in men older than 50 years and 9% in women post-menopause. It has 
been reported that prevalence of OSA has increased since 1990 in the United States 
and other countries. However, 80% of individuals with OSA remain undiagnosed 
and untreated [2].
The pathophysiology of OSA includes oxygen desaturation, alteration in sleep 
architecture and abnormal ventilation [3]. Hypoxemia and sleep fragmentation 
(arousals) cause excessive daytime sleepiness increasing the risk of road and work 
accidents [4] and reduced quality of life [5]. Additionally, OSA increase the risk 
of cardiovascular, cerebrovascular and metabolic diseases [6], neurocognitive 
impairment [7] and death [8]. One at time, cardiovascular diseases and metabolic 
consequences of OSA increase the risk of cognitive impairment. Cognitive deficits 
in individuals with OSA include attention and vigilance, episodic memory, delayed 
long-term visual and verbal memory, visuospatial/constructional abilities and 
executive functions [9–11]. Some studies reported that psychomotor function and 
Sleep Medicine in Clinical Neurology
2
language do not seem compromised, [12] whereas others demonstrated to psycho-
motor function is affected by OSA and this domain does not improve with CPAP 
therapy [13]. Although the cognitive impairment in individuals with OSA is largely 
recognized as mild cognitive impairment, [14] OSA has also recognized as modifi-
able risk for dementia, neuropsychiatric disorders and stroke [15, 16]. However, the 
pathophysiology of cognitive impairment in adults with OSA is complex and the 
whole mechanisms involved in cognitive deficit have not been clarified yet.
2. Sleep’s role in memory
Since, Hervey de Saint Denys published Les Rêves et les Moyens de les Diriger in 
1867, was established that sleep benefits the retention of memory [17]. Rosa Heine 
was the first person, in 1914, who demonstrated that learning before a period of 
sleep results in a lower rate of forgetfulness in the following 24 hours than learning 
before a period of wakefulness. These results demonstrated the importance of sleep 
for memory. Likewise, Ellenbogen et al. showed that sleep after learning benefits 
the consolidation of memories and strengthens the traces of memory against future 
interference. Current research findings show an active sleep role in the consolida-
tion of memory, learning and brain plasticity [18].
Sleep is defined as “a natural and reversible state of reduced response to external 
stimuli and relative inactivity, accompanied by decreased consciousness” [19]. 
Sleep has four basic states, rapid eye movement (REM), no REM sleep 1 (N1), 
NREM sleep 2 (N2) and NREM sleep 3 (N3). Slow wave sleep (SWS) is observed 
in N3. In humans, SWS predominates in the early stages of the sleep and REM 
in the final period, alternating in a cyclic manner. In terms of memory, forming 
and recovering memories is a fundamental ability to achieve adaptation. Memory 
functions involved different process such as encoding, consolidation and retrieval. 
During encoding, the stimulus results in the formation of a new memory fragment 
that is stabilized in consolidation process avoiding forgetting and incorporating the 
memory into preexisting knowledge complexes. Consolidation occurs during SWS 
and REM sleep stabilizes transformed memories [20, 21]. Also, it has been sug-
gested the possibility that cholinergic tone during delayed REM sleep is necessary 
for the successful consolidation of memory [22, 23].
Theories that propose a differential role of the sleep stages in memory are based 
on the “dual process hypothesis.” In this dual hypothesis, SWS has a benefit in the 
declarative memories of events, such as learning word lists, word pairs or spatial 
locations, and processing dependent on the hippocampus [24], while REM sleep, 
benefits the consolidation of non-declarative memories (related to procedural 
memory, including mirror tracing, priming, implicit memory, and the emotional 
modulation of memories). A complex learning task can often involve both proce-
dural and declarative learning components (complex motor movements, language 
learning). Emotive and sensitive events are better evoked than neutral ones, due 
to stimuli of the amygdala in the process of coding in the hippocampus. Changes 
registered in REM sleep for patients with mood disorders and lived dreams, clarify 
the link between REM sleep and the increase in amygdala activity. This activity has 
been related with the emotive and sensitive recycling during this stage of sleep. 
REM sleep seems also to be related with strength and weakened of emotional 
memory [25]. Findings from electroencephalogram (EEG) and functional magnetic 
resonance imaging (fMRI) show activity in brain regions (hippocampal) correlated 
with REM and SWS sleep, following both declarative and procedural learning. 
Although other theories hypothesized that memory consolidation occurs during 
different sleep states [26], neural processes of memory consolidation have been 
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observed during sleep and wakefulness [27]. Additional findings show that sleep 
enhances memory performance in brain-damaged individuals, except in patients 
with Parkinson [23].
The effect of sleep on memory is lasting and adaptive. Coding and initial 
recovery depends on the integrity of the hippocampus. The beneficial effect of sleep 
is linked to the interaction between slow oscillatory activity during SWS, thalamo-
cortical sleep spindles and spontaneous reactivations of hippocampal memory [28]. 
In humans, slow wave sleep is correlated with hippocampus-dependent memory 
and REM sleep is associated with emotional memory. Currently, it is considered 
that an active consolidation of memory is established specifically during sleep and 
originates from the reactivation of newly coded memory representations that are 
integrated into the long-term knowledge networks. Findings from fMRI suggest 
that the process of consolidation in declarative memory is gradual. Then, the early 
activity after learning is observed in hippocampal locations, and after reinforced 
during sleep, long-lasting changes of memories are observed in medial prefrontal 
cortical activity. REM and NREM sleep are important for preservation, integration, 
and recollection of episodic memory [29]. In summary, sleep enhances learning of 
skills, semantic, episodic and emotional memories and stimulates creativity.
Some factors such as age, psychiatric and neurodegenerative conditions, sleep 
disruption and sleep apnea impair episodic memory [30, 31]. In patients with OSA 
cognitive processing, memory, vigilance, divided attention and executive function-
ing are affected. These deficits are observed identifying decreased ability to digest 
information, decreased ability to register, store, retain, and retrieve information, 
inability to maintain attention over the time, inability to respond to more than 
one task or stimuli, disorganization, emotional liability, impulsivity and difficulty 
maintaining motivation [32]. Beyond physiologic functions, the role of sleep in 
brain plasticity and memory consolidation processes is relevant, but the mecha-
nisms involved in these processes remain to be fully understood. Therefore, it is 
necessary to perform future investigations to elucidate the pathophysiology of sleep 
disorders in neurocognitive impairment.
3. Physiopathology of cognitive impairment in obstructive sleep apnea
Neurocognitive impairment has over the years been associated with OSA but 
the prevalence of neurocognitive impairment in patients with OSA is not known 
[12]. One in four patients with OSA has neurophysiological impairment [33]. OSA 
patients are 7.5 to 20 times more likely to have difficulties with concentration, learn-
ing new tasks and execution monotonous tasks [34]. While current test for cogni-
tion not specifically assess impairments in OSA [35], some studies suggest that in 
the association between OSA and cognitive dysfunction, multitude of susceptibility 
and protective factors have been including, but others important factors should 
be considered. Susceptibility factors associated with neurocognitive impairment 
include: increased nocturnal awakenings, latency to REM sleep, [36, 37] changes 
in cerebral blood flow, neurovascular and neurotransmitter changes, intermittent 
hypoxemia, neuroinflammation, oxidative stress, ischemic precondition, hyper-
capnia [38, 39] and neural regulation in OSA [40]. Nevertheless, it is necessary to 
investigate the role of other factors such as genetic susceptibility, duration of OSA, 
hypertension, metabolic dysfunction, systemic inflammation, cerebral blood flow 
and blood-brain barrier [41].
Excessive daytime somnolence exhibit in patients with OSA increase the risk 
of cognitive decline and dementia. Sleep deprivation impair neuronal excitability, 
decrease myelination, produce cellular oxidative stress, misfolding of cellular 
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proteins, and alter molecular signaling pathways that regulate synaptic strength, 
plasticity-related gene expression and protein translation. These alterations create 
microinfarcts and brain atrophy that are associated with lower nocturnal oxygen-
ation and reduction in NREM SWS sleep [42–44]. In OSA the proportion of stage 
N2 NREM sleep is increased and proportions of stages N1, N3 and REM sleep are 
decreased. During the NREM SWS abstraction of rules and integration of knowl-
edge take place while in REM sleep creativity is beneficiated. In patients with OSA 
both sleep stages are reduced and fragmented, suggesting that some of the cognitive 
impairment is due to this dysregulation [45–47]. Frequently, obstructive events 
during NREM sleep have been associated with cognitive deficits and REM sleep 
events have been associated with greater sympathetic activity, hypertension and 
cardiovascular instability in patients with OSA. However, some studies reported 
that OSA reduction of REM sleep produce dissociation of REM traits to other sleep 
stages, affecting memory formation and consolidation [48, 49]. Gray matter atro-
phy in the prefrontal cortex observed in OSA and aging can mediate the degree of 
SWS disruption and consequent impaired overnight episodic hippocampal memory. 
Although several models have been proposed to explain the pathophysiology of 
cognitive impairment in OSA patients, the exact mechanisms of this association 
remain elusive [40, 50].
It has been suggested in meta-analysis and systematic review that cognitive 
deficit in patients with OSA is the result of poor night-time sleep and changes 
in the brain. Hypoxemia produces alteration of the prefrontal cortex and other 
CNS regions [51]. Then, global cognitive function is associated with hypoxemia 
and attention and vigilance dysfunction with sleep fragmentation. Sleep frag-
mentation is produced by the frequent sleep arousals that associated with apneic 
episodes contribute to abnormal sleep architecture, less restorative sleep and 
increased daytime sleepiness [14]. Therefore, treatment with continuous posi-
tive airway pressure (CPAP), should improve cognition and sleepiness. Evidence 
from clinical trials demonstrate that CPAP improves attention, vigilance memory 
executive functions and sleepiness, but deficits in learning memory and psycho-
motor function persist [52]. These findings suggest that improvements in sleepi-
ness is not always associated with improvements in cognition, and it has been 
suggested that the improvement of cognition could be related with duration and 
severity of OSA [53].
Large-scale, multicenter, randomized, double-blind cohort study, the Apnea 
Positive Pressure Long-term Efficacy Study (APPLES), investigated the effects of 
CPAP on cognitive function in patients with OSA [53]. In this study, patients with 
severe OSA improved more than those with mild OSA. Although attention/psy-
chomotor and learning/memory functions did not improve at either the 2-month 
or 6-month follow-up, improvement in the verbal delayed recall test was observed 
in patients on CPAP for 6 hours a day. Therefore, it was suggested that long-term 
memory deficits might be reversible with optimized CPAP treatment. Other studies 
following 3 and 12 months of treatment with CPAP show changes in gray frontal 
and hippocampal regions) and white matter correlated with improvements in 
memory, attention and executive functions [54, 55].
While several studies show that CPAP improves some cognitive domains, other 
studies reported less responsive for psychomotor activities. Additionally, the rela-
tionship between cognitive impairment and OSA severity is complex and the find-
ings are inconsistent [9]. This complexity is represented by individual differences, 
genetic profiles and difficulties to measure OSA severity and cognitive impairment. 
Sleepiness questionnaire scores are not objectives and AHI (apnea/hypopnea index, 
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number of apnea and hypopnea events per hour of sleep) cannot measure the indi-
vidual differences in the length of each event. Furthermore, oxygen desaturation 
index cannot identify the sleep cycle when hypoxia and arousal occur. Therefore, 
novel measures that separate sleep fragmentation and oxygen desaturation and 
measures to identify these events in each sleep cycle because cognitive functions are 
related with sleep cycles are needed [41].
Several factors contribute to individual differences in the relationship between 
OSA and cognition. Aging is associated with changes in morphology, size and 
reflex sensitivity of upper airway, resulting in a reduction in upper airway dila-
tor muscle function at sleep in older people [56, 57]. Also, it has been suggested 
that co-morbidities such as hypertension, hyperlipidemia, diabetes, metabolic 
syndrome, and Alzheimer disease are the primary causes of the neurological dam-
age. Other individual differences are related with genetic predisposition, mood, 
changes in macro and microcirculation in the brain, gender and experience of 
sleepiness [58].
4. Brain changes associated with OSA
There is evidence of structural and functional brain changes in critical areas 
for cognition in patients with OSA. Numerous investigations have reported 
changes in the electroencephalogram of OSA patients compared with healthy indi-
viduals. These changes show abnormal cortical excitability associated with neuro-
cognitive deficits [59, 60]. In the prefrontal model sleep disruption, intermittent 
hypoxemia, and hypercapnia observed in OSA produce cellular and biochemical 
stresses that alter neuronal and glial viability within prefrontal regions of the 
brain cortex, affecting the efficacy of restorative process occurring during sleep. 
This model explains the relationship between sleep fragmentation and nocturnal 
hypoxemia with predominantly frontal deficits. However, the neuroanatomic 
regions that have most commonly been reported in OSA are thalamus and fronto-
parietal cortex [61]. Degenerative areas in brain include: hippocampus (memory 
and new learning), the thalamus (sensory and motor signaling and in regulating 
sleep and alertness) and the amygdala (regulation of emotion) [16]. The findings 
in fMRI suggested a dysfunctional connectivity of the posterior default mode 
neuronal network and changes in network in the anterior insula, posterior-medial 
frontal cortex and thalamus (right amygdala-hippocampus complex and the 
insular cortex) [62, 63].
Several studies reported that OSA is a risk factor for cerebral small vessel disease 
(C-SVD). C-SVD is a group of pathologic processes that affect small arteries and 
veins, arterioles, and capillaries. Restricted blood flow in diseased small vessels, 
produce low perfusion pressure and hypoperfusion of the affected brain areas. 
Subsequently, chronic hypoperfusion develop ischemic C-SVD [64, 65]. Changes in 
white matter associated with OSA has also been reported. Degradation of multiple 
areas of subcortical tracts of the superior and inferior parietal lobe, deep frontal 
white matter and arcuate fasciculus. The white matter fiber integrity was recuper-
ated after 12 months of CPAP treatment and this recuperation was associated with 
improvement in memory, attention, and executive functions [55]. The gray matter 
is also affected in patients with OSA. Some studies report that extent of gray matter 
volume loss increases correlated positively with OSA severity. Decreased gray 
matter has been observed in the frontal and parietal cortex, temporal lobe, anterior 
cingulate, hippocampus, and cerebellum [66, 67] (Figure 1).
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5. Mechanisms associated to cognitive impairment in OSA
OSA causes oxygen desaturation producing arousals and nocturnal intermit-
tent hypoxemia. The intermittent hypoxia is linked to cerebral microvascular 
and neurovascular changes. Several models have been proposed to explain the 
pathophysiology of neurocognitive impairment in patients with OSA. Some of these 
models include: prefrontal model sleep disruption, neuroinflammatory process, 
hypoperfusion and endothelial dysfunction. Neuroinflammatory process is one of 
the mechanisms proposed to explain the association between OSA and cognitive 
impairment. Healthy microglia of central nervous system (CNS) show a surveil-
lance phenotype that synthesizes neuroprotective growth factors. In OSA ischemic 
condition actives several genes including vascular endothelial growth factor 
(VEGF), erythropoietin, atrial natriuretic peptide (ANP), hypoxia inducible fac-
tor-1 (HIF-1), and brain-derived neurotrophic factor (BDNF) [68]. Altered resting 
cerebral blood flow pattern and hypoperfusion in several CNS regions have been 
demonstrated in patients with OSA during sleep and awake states [69]. Repetitive 
hypoxia and reoxygenation promote oxidative stress producing blood-brain bar-
rier hyperpermeability and neuroinflammation. These alterations result in plasma 
proteins leaking into the arteriolar walls and perivascular spaces (Virchow-Robin 
spaces) and subsequent accumulation of macrophages and fibrosis in the arteriolar 
walls leading to the development or progression of C-SVD. Severe and prolonged 
hypoxia can activate microglia toward a toxic, pro-inflammatory phenotype causing 
white matter damage and lacunar infarction and accumulation of plasma proteins 
in the small arterial walls. Additionally, inflammation at the blood-brain barrier 
alters the transport of molecules across the barrier, resulting in progressive synaptic 
plasticity and neuronal dysfunction. This maladaptive neuroinflammatory process, 
observed in patients with OSA, increases hippocampal apoptosis, impaired synaptic 
plasticity, and cognitive impairment [70–74].
In hypoperfusion model, the cognitive impairment is explained in this way: 
in normal conditions the cerebral autoregulation mechanism protects the brain 
through maintaining cerebral perfusion during blood pressure changes. In OSA 
this system is impaired because of changes in nocturnal intracranial hemodynam-
ics and oxygen saturation, resulting in cerebral hypoperfusion in the regions with 
poor collateral circulation. Chronic hypoperfusion in small arteries and arterioles 
leads to ischemic changes in white and gray matter. Although cerebral blood flow 
is increased to compensate for oxygen desaturation in patients with OSA, this 
mechanism is not enough and the chronic hypoxemia promotes the progression of 
C-SVD resulting in lacunar infarcts, white matter abnormalities and gray matter 
Figure 1. 
Magnetic resonance imaging in patient with cognitive impairment and OSA and in healthy individual.
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loss. Damage to prefrontal and frontal lobes, basal ganglia and hippocampus are 
associated with abnormal myelin and axonal integrity. Prolonged hypoxic–ischemic 
damage to the frontal and prefrontal cortex is associated with executive dysfunction 
in patients with moderate to severe OSA, but this damage could improve with CPAP 
treatment [75–79].
In endothelial dysfunction model, neurocognitive impairment is produced 
for several mechanisms. The apneic episodes cause repetitive intracranial blood 
flow impairing the endothelial cells of small arteries and arterioles and decreasing 
endothelial vasodilator production. Nitric oxide regulates cerebral blood flow in 
response to hypercapnia, but in OSA nitric oxide is decreased, and the vasodilatory 
capacity of cerebral vasomotor reactivity in response to hypercapnia is compro-
mised. Altered cerebral vasomotor reactivity associated with poor microvascular 
blood flow produce white matter lesions. Additionally, disruption of nitric oxide 
pathways causes a cascade of neuronal metabolic deficiencies, resulting in destabi-
lizing neurons, synapses, and neurotransmission, and generating synaptic loss and 
neuronal damage [80–83].
Investigations about the impact of patients with OSA treated with CPAP in the 
cognitive function have showed that daytime sleepiness decrease and cognitive 
function improves. The amount of improvement depends of biologic variability 
present in each patient [55, 84, 85]. Previous studies had been demonstrated that 
sleep disruption impaired cognitive function and the mechanisms of cognitive harm 
in OSA and chronic obstructive pulmonary disease (COPD) are similar. However, 
the pathophysiology of neurocognitive impairment in OSA and insomnia seems 
to be different, and the cognitive deficit in individuals with OSA is greater [46, 85, 
86]. Therefore, other mechanisms such as changes in the brain could explain the 
cognitive impairment associated with OSA. Additionally, in some patients with OSA 
cognitive deficit persist, even after prolonged treatment with CPAP. For this reason, 
it is necessary to design future studies to identify appropriate treatment that can be 
administered before irreversible atrophic and metabolic changes occur [41, 87, 88]. 
Further studies should be performed to elucidate mechanisms of neurocognitive 
impairment and to identify genetics profiles for prediction of neurocognitive effects 
of CPAP in patients with OSA and other comorbidities.
6. Conclusions
• Obstructive sleep apnea is associated with cognitive impairment and is a 
modifiable risk factor for dementia.
• Sleep fragmentation, hypoxia, maladaptive pathways, neuroinflammation, 
hypoperfusion and endothelial dysfunction contribute with neurocognitive 
impairment in patients with OSA.
• Future studies should be conducted to identify novel diagnosis and therapeutic 
tools for OSA and cognitive impairment.
• The exact pathophysiology of cognitive impairment in OSA patients remain 
elusive as the role of therapy for OSA on cognitive impairment.
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